Form 4: iRhythm Holdings Executive Sells Shares

iRhythm Holdings executive Minang Turakhia sold 1,423 shares of common stock on July 2, 2026, for tax withholding purposes.

Summary

• Minang Turakhia, Chief Medical/Scientific Officer and EVP of Advanced Technology at iRhythm Holdings, Inc., sold 1,423 shares of common stock.
• The transaction occurred on July 2, 2026, with a sale price of $124.71 per share.
• These shares were sold to cover tax withholding and remittance obligations related to the vesting of Restricted Stock Units (RSUs).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can be a negative signal, the stated reason for the sale (tax withholding) is a common and expected occurrence, mitigating significant negative sentiment.

Negatives

• Sale of company stock by an executive, although for tax withholding, can sometimes be perceived negatively by the market.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider sales, even for tax withholding, are common events for executives managing equity compensation. The price at which these shares were transacted provides a data point for current executive valuation of the stock.

Stakeholder Impact

• Shareholders: The sale is for tax withholding, so it does not necessarily indicate a lack of confidence in the company's future. However, any insider selling can create short-term market perception shifts.
• Employees: The transaction relates to executive compensation (RSUs) and does not directly impact general employee compensation or benefits.
• Management: The transaction is a standard part of managing executive equity compensation.

Key Dates

Keywords

iRhythm Holdings, IRTC, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Tax Withholding